LUNA:VIE
H Lundbeck A/S Class A
7,72 €
arrow_upward
+1,45%(+0,11) 1D
13 նոյ, 13:00:31 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUNA...
Open
7,75 €
High
7,75 €
Low
7,55 €
Mkt. cap
58,13 մլրդ
Avg. vol.
143,00
Volume
9,00
52-wk high
8,17 €
52-wk low
4,22 €
No. of employees
5 հզր
Open
7,75 €
High
7,75 €
Low
7,55 €
Mkt. cap
58,13 մլրդ
Avg. vol.
143,00
Volume
9,00
52-wk high
8,17 €
52-wk low
4,22 €
No. of employees
5 հզր
News stories
From web sources and news partners
TradingView
·
1 օր առաջ
H. Lundbeck Q3 2026 Earnings Call Is Live
Morningstar
·
1 օր առաջ
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
1 օր առաջ
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
2 օր առաջ
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A